The lung clearance index (LCI) derived from the multiple breath inert gas washout (MBW) test reflects global ventilation distribution inhomogeneity. It is more sensitive than forced expiratory volume in 1 s (FEV 1 ) for detecting abnormal airway function and correlates closely with structural lung damage in children with cystic fibrosis, which shares features with primary ciliary dyskinesia (PCD). Normalised phase III slope indices S cond and S acin reflect function of the small conducting and acinar airways, respectively. The involvement of the peripheral airways assessed by MBW tests has not been previously described in PCD. Methods A cross-sectional MBW study was performed in 27 children and adolescents with verified PCD, all clinically stable and able to perform lung function tests. LCI, S cond (n¼23) and S acin (n¼23) were derived from MBW using a mass spectrometer and sulfur hexafluoride as inert marker gas. MBW indices were compared with present age, age at diagnosis and spirometry findings, and were related to published normative values. Results LCI, S cond and S acin were abnormal in 85%, 96% and 78% of patients with PCD and in 81%, 93% and 79%, respectively, of 13/27 subjects with normal FEV 1 . LCI and S acin correlated significantly while S cond did not correlate with any other lung function parameters. None of the lung function measurements correlated with age or age at diagnosis. Conclusions PCD is characterised by marked peripheral airway dysfunction. MBW seems promising in the early detection of lung damage, even in young patients with PCD. The relationship of MBW indices to the outcome of long-term disease and their role in the management of PCD need to be assessed.
INTRODUCTION
Primary ciliary dyskinesia (PCD) is a rare congenital disease characterised by defective ciliary function, which leads to impaired mucociliary clearance and consequently to recurrent and chronic upper and lower airway infections. 1 2 Patients with PCD most often present with persistent rhinitis and chronic productive cough, but the heterogeneous nature of the disease makes early diagnosis difficult. 3 A recently published longitudinal study from our centre suggested that PCD is a disease which seriously compromises lung function already at preschool age with a highly variable course of forced expiratory volume in 1 s (FEV 1 ) and forced vital capacity (FVC) even after early diagnosis. 4 However, traditional spirometry is mostly sensitive in detecting proximal airway disease, which may have limitations as early lung damage in PCD may be of peripheral origin. This is supported by a case report in which two of three patients with PCD who had infant pulmonary lung function performed demonstrated values suggestive of primary pathology in smaller peripheral airways. 5 PCD lung disease shares several features with cystic fibrosis (CF): clinical findings include chronic productive cough and, although less frequent, colonisation by Pseudomonas aeruginosa (PA), 6 and radiological changes include bronchiectasis, mucus plugging and peribronchial thickening. 7 However, although data on early structural changes in PCD lung disease are lacking, it is reasonable to suggest that PCD may resemble CF in which initial lung damage has been shown to start in the peripheral airways. 8 In CF, spirometry has traditionally been used to monitor lung function, but several studies have shown spirometry to be insensitive in tracking early progressive lung disease. 9e12 The lung clearance index (LCI), derived from a multiple breath inert gas washout test (MBW), is a measure of global ventilation inhomogeneity (VI) and small airway dysfunction. LCI has been shown to detect lung damage in CF more readily than other pulmonary function tests 9 13 and to be predictive of subsequent lung function when measured at preschool age. 10 In addition, determination of concentration normalised phase III slope (Sn III ) indices allows assessment of VI arising in the small conductive airway zone (S cond ) and more peripherally close to or within the acinar airway zone (S acin ).
14 Peripheral airway function assessed by LCI, S cond and S acin in children and adolescents with PCD has not been previously reported.
The aim of our study was to assess peripheral airway function in children and adolescents with PCD using MBW and to compare the findings with spirometry. We hypothesised that PCD lung disease is characterised by marked peripheral dysfunction, and that abnormal ventilation distribution is a frequent finding despite normal spirometry. Some of the study results have been previously reported in abstract form. 15 
METHODS

Design of study
This was a cross-sectional prospective study. All patients had lung function and MBW tests performed at their routine annual review at the National Danish PCD Center. Management is according to previous publications from the same centre. 4 < Additional data are published online only. To view the file please visit the journal online (http://thorax.bmj.com/content/ 67/1.toc).
Study patients
Patients with a diagnosis of PCD aged #18 years were eligible for the study. All patients had a consistent history of symptoms characteristic of PCD, 16 17 and basic tests to rule out CF and immunodeficiency were performed. Nasal nitric oxide measurement (nNO) was used as a preliminary screening test, although without necessarily excluding patients with a high suspicion of PCD. 18 Furthermore, functional studies on ciliary beat pattern and frequency analysis using video recording and electron microscopy (EM) analysis of ciliary ultrastructure were key diagnostic tests. 1 Functional studies were performed twice, at least one month apart. Patients had to be considered in a stable clinical condition on the day of MBW measurement.
Measurements MBW
Tidal breathing sulfur hexafluoride (SF 6 ) washout was performed in all patients using a mass spectrometer (AMIS 2000, Innovision, Odense, Denmark) for gas analysis, as previously described. 13 The LCI and the concentration normalised slope III indices (S acin and S cond ) were calculated. LCI was calculated as the number of lung volume turnovers (TO; ie, the cumulative expired volume divided by the functional residual capacity, FRC) needed to lower the end-tidal tracer gas concentration to less than 1/40th of the starting concentration. 13 The mean LCI result from three MBW measurements in each patient was used for analysis. The concentration normalised slope of phase III (Sn III ) for each subsequent breath during MBW was determined to calculate S cond and S acin . The phase III slope was converted to Sn III by dividing the slope by the mean gas concentration over the slope to allow for gas dilution. The Sn III was further multiplied by tidal volume (VT) giving the Sn III 3 VT in order to account for inter-individual differences in lung size and breathing pattern. 19 The Sn III 3 VT was used in all subsequent analyses and is henceforth referred to as Sn III in this paper. For determination of S cond and S acin , Sn III and TO values for each subsequent breath from the three washouts were first averaged. For each breath, Sn III was then plotted against the corresponding TO value. S cond was defined as the rate of Sn III increase between TO 1.5 and 6.0. S acin was defined as the first breath Sn III value minus the convection-dependent inhomogeneity contribution to this value (ie, S cond 3 TO for the first breath). MBW results from this study were compared with data previously collected in healthy Swedish schoolchildren obtained using identical equipment, software and procedures. 13 20 The authors performing and calculating the MBW tests have undergone training and been under continual supervision by the Swedish laboratory. Further technical details and reference values of the MBW technique are provided in the online supplement and elsewhere. 20 
Spirometry
Spirometry was performed according to ATS/ERS standards 21 and FEV 1 , FVC, forced expiratory flow at 25e75% of FVC (FEF 25e75 ) and FEV 1 /FVC ratio were recorded. The recently published 'all ages' reference equations were used. 22 Abnormal lung function was defined as z-scores <À1.96.
Statistical analysis
Lung function was expressed as z-scores, which were calculated as (measured value À predicted value)/RSD from the reference population. 22 The upper limit of normal (ULN) was defined as the predicted mean plus 1.96 RSD for MBW variables and the lower limit of normal (LLN) as predicted mean minus 1.96 RSD for spirometry variables. MBW parameters were correlated to spirometry parameters, age and age at diagnosis using a linear regression model. A p value of <0.05 was accepted as statistically significant. SAS V.9.2 (SAS Institute) was used for statistical analyses.
RESULTS
Twenty-seven patients with PCD from the National Danish PCD cohort were included in the study; all patients had LCI measurements performed. Sn III indices could not be calculated in four patients owing to irregular breathing patterns. In two patients spirometry was performed on a separate day because of technical problems and the dataset closest in time to the date of the MBW test (5 weeks later) was used instead. Both patients were clinically stable on the day spirometry was performed, and spirometry showed stable measurements over time.
Three patients did not have a conclusive abnormal ciliary beat pattern and frequency during the investigation. One had clinical signs and symptoms of PCD, situs inversus, hydrocephalus, repeated abnormal pulmonary radioaerosol mucociliary clearance tests, 23 borderline abnormal nNO, low exhaled NO measurements <5 ppb, but conflicting functional studies not certain of abnormal beat pattern and an EM without classical ultrastructural defects. Two other patients did not have a conclusive ciliary function test as they both refused to participate in further functional studies after the initial one: one patient had classical clinical PCD, extremely low nNO and classical abnormal EM; the other had classical clinical PCD and an abnormal EM and very low nNO. In addition, the latter had a brother with PCD with identical EM presentation and immotile cilia on functional studies. Demographic and diagnostic characteristics are shown in The relationships between LCI and the Sn III indices S acin and S cond are shown in figure 1A and B. LCI correlated to S acin (R 2 ¼0.45; p<0.001) but not to S cond . S cond peaked at an LCI of about 10 z-scores, subsequently decreasing with increase in disease severity (as measured by LCI). S acin and S cond did not correlate ( figure E1 in online supplement) .
Mean values of spirometry parameters across the cohort were within or close to normal limits; 52% (14/27) had abnormal FEV 1 and 15% (4/27) had abnormal FVC.
LCI did not show a statistically significant correlation with either FEV 1 or FVC. LCI, S cond and S acin were abnormal in 81% (13/16), 93% (13/14) and 79% (11/14) , respectively, among the 13/27 patients with normal FEV 1 (figure 2AeC). Normal LCI excluded the presence of abnormal FEV 1 , with the exception of a marginally reduced FEV 1 (À2.1 z-scores) in one patient. In addition, this patient had S acin within the normal range while S cond was elevated at more than 10 z-scores. When relating Sn III indices to spirometry parameters, neither S acin nor S cond correlated with FEV 1 or FVC.
The inclusion of spirometry results performed for two patients on a different date from the MBW did not have any effect on the statistical analysis with regard to FEV 1 and FVC. Correlations between lung function parameters are summarised in table E1 in the online supplement.
There was no significant correlation between any of the lung function parameters and age or age at diagnosis, respectively. Table E2 in the online supplement shows correlations between MBW indices and age and age at diagnosis.
Comparisons between MBW parameters and FEF 25e75 and FEV 1 /FVC ratio are given in the online supplement.
DISCUSSION
This is the first report presenting data from MBW findings in a cohort of well-characterised children and adolescents with PCD. We found that MBW was more frequently abnormal than FEV 1 , the currently accepted spirometry surrogate marker of disease severity. Abnormal LCI was found in nearly all patients, including those with normal FEV 1 . Additionally, S cond was abnormal in all but one patient and S acin in more than threequarters of the patients, implying involvement of small airways even beyond the conducting airway zone. MBW parameters did not correlate with FEV 1 or FVC. Measures of spirometry were on average all within or close to normal values and half the patients had normal FEV 1 , while the indices of VI were considerably elevated. Our findings show that PCD lung disease is characterised by marked peripheral dysfunction which, in most cases, is not detectable by spirometry.
The results of this study are consistent with previous publications showing that MBW is more sensitive than spirometry in detecting pulmonary diseases such as CF. 9 12 13 24 25 To our knowledge, the only other information to date on MBW data in PCD is an abstract by Ives et al who investigated adult patients with PCD, thus making direct comparison with our study difficult. 26 In a recent large longitudinal study in the Danish PCD cohort published from our centre 4 we found a high degree of variation in the course of lung function after diagnosis. This variation could not be linked to age or to the level of lung function (ie, spirometry findings) at the time of diagnosis, with the Demographic data were not normally distributed so are presented as median (range). Diagnostic characteristics are presented as n. *Sum >25 as each patient can have more than one functional abnormality.
conclusion that early diagnosis and initiated treatment, even in a tertiary centre, does not protect against decline in lung function. 4 This is in line with the current study where we did not find any relationship between the degree of VI and age at diagnosis of PCD. Possible explanations are that (1) our current monitoring and management of patients with PCD is based on extrapolation of CF care which may not be sufficient; and (2) changes in spirometry values are unable to detect early lung damage as implied by our study. The latter may cause a delay in intensification of treatment when needed.
Results from studies in children and adults with CF suggest that Sn III analysis is of limited use in more advanced disease. 27 Consistent with this view, we found S cond to be markedly elevated even in patients with mild disease, as indicated by LCI or spirometry. In our cross-sectional analysis, S cond reached a plateau and then declined with higher LCI. S cond results from differences in specific ventilation and sequential filling and emptying among lung regions sharing branch points in the conducting airway zone. This index thus reflects the 'patchiness' of disease distribution. With increasing disease severity, ventilation of already poorly ventilated lung units will come to an end and inter-regional differences in ventilation nonuniformity will not increase additionally. At the same time, it could be speculated that disease progression in a distal direction and the movement of the diffusion front in a proximal direction will lead to further elevated S acin . As expected, S acin was more closely associated with LCI in advanced disease. In severe disease, spirometric lung volumes and forced expiratory flows are also markedly reduced due to gas trapping and because poorly ventilated regions can no longer be compensated for by increased flow through non-flow-limited distal airways. 28 Despite abnormal FEV 1 , one patient presented with normal LCI and S acin but with highly elevated S cond . In children with asthma, Gustafsson 29 has previously shown a more profound involvement of the small conductive airways, represented by markedly elevated S cond , in comparison with the other VI indices. In asthma, S cond is thus a more sensitive MBW index than LCI. The present finding could therefore be due to the presence of underlying (undiagnosed) asthma. Further studies in patients with PCD assessing bronchodilator response are consequently warranted. However, we believe that raised S cond reflects a similar patchiness of disease distribution among lung units as in asthma. The finding of markedly abnormal S acin values in the majority of the patients with PCD suggests that PCD airway disease generally involves more peripherally located airway generations than asthma and that, in this respect, PCD resembles CF more than asthma.
In our study three patients did not have a conclusive abnormal ciliary beat pattern and frequency. Ciliary beat pattern and frequency and EM analysis play a key role in diagnosis, but PCD is likely to include a small number of phenotypes that may be manifested by subtle or no apparent structural defects and ciliary dysfunction. Consequently, studies have documented the occurrence of normal ciliary structure 30e32 and function 30 in patients with verified PCD. All three patients had abnormal MBW parameters while FEV 1 and FVC were within the normal range (see table E3 in online supplement).
Limitations of the study
One limitation of our study is the lack of Danish MBW reference material. Instead, we used Swedish normative data as reference which were obtained using exactly the same equipment, software and procedures. In addition, the authors performing and calculating MBW tests have undergone training and have been under continual supervision by the Swedish laboratory in order to affirm the quality of the measurements.
MBW changes in PCD might reflect retained mucus in the airways resulting in VI. If so, MBW measures could improve following coughing, airway clearance manoeuvres or aerobic exercise. This study would be strengthened with additional information about variability in MBW measures in PCD, such as day-to-day variability, morning versus afternoon variability, before and after controlled coughs or before and after airway clearance manoeuvre. Furthers studies on these important methodological aspects are needed. Abnormalities of peripheral airway function might reflect potentially reversible PCD lung pathology. Owing to their sensitivity to peripheral airway dysfunction, MBW tests have the potential to be used to signal the need for and to monitor the effects of early intervention and more aggressive treatment with the aim of preventing irreversible lung damage. As PCD is associated with a progressive and continuous impact on both physical and mental health, 33 identification of children with early lung damage could lead to earlier and more aggressive intervention and, consequently, a better prognosis and quality of life over time.
In conclusion, our study demonstrates for the first time that MBW measures of peripheral airway function are abnormal in young patients with PCD, being far more frequent findings than abnormal spirometry. The study shows that PCD lung disease is characterised by marked peripheral dysfunction and that MBW is a promising and feasible method for early detection of airway disease in PCD. Further prospective controlled longitudinal studies assessing the utility of MBW in the management of PCD and their importance for long-term outcome are warranted.
